• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; IMPLANTABLE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; IMPLANTABLE DEVICE Back to Search Results
Model Number G447
Device Problems Premature Discharge of Battery (1057); Failure to Capture (1081); Pocket Stimulation (1463); Low impedance (2285); High Capture Threshold (3266)
Patient Problem Muscle Stimulation (1412)
Event Date 07/07/2019
Event Type  Injury  
Manufacturer Narrative
The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) and left ventricular (lv) lead exhibited high threshold measurements, loss of capture (loc) and low out of range pacing impedance measurements less than 200 ohms 13 days post implant.Additionally, the device showed a battery status of 1 year remaining.The lead configuration was reprogrammed and capture was obtained, however, the patient experienced muscle stimulation, so the lead was programmed off.A copy of device memory was submitted for analysis.Analysis of device memory noted a high power consumption condition and device replacement was recommended and troubleshooting options were discussed for the lv lead.An invasive procedure was performed.The pocket was opened and lead to device header connections were verified to be appropriate.The device was explanted.The lv lead was then tested on a pacing system analyzer (psa) and pacing impedance measurements were noted to be within normal limits at 297-317 ohms.The lead position was verified to be appropriate under fluoroscopy.The lead configuration was reprogrammed and appropriate capture was observed with no stimulation.A new device was successfully implanted with the chronic lv lead.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Detailed testing isolated the high current condition to an anomaly of the transistor gate oxide within the analog pacing block.The oxide glass layer is intended to serve as a non-conductive insulator, but unintended metal impurities in the glass layer can create an inappropriate conductive pathway between two adjacent conductive metal layers.Also, because these layers are very thin, empty voids or bubbles within the glass can provide a pathway for current leakage if sufficient voltage is applied to the conductive layers on either side of the void.This pathway can be latent with minuscule current leakage.Over time, voltage stress can increase current leakage, which may alter component/device function, increase overall current drain, and deplete the battery prematurely.Boston scientific has worked with integrated circuit manufacturers to implement continuous manufacturing improvements over time to reduce oxide defects, such as improving purity of the materials used, tightening manufacturing clean room particle count specifications, and improving handling and inspection techniques.The supplier implemented a hydrochloric acid (hcl) rinse to their manufacturing process in december 2015.However, medical device manufacturers are subject to the inherent limitations of current integrated circuit technologies.Additionally, a test was added to the manufacturing process to identify issues prior to the release of product.
 
Event Description
It was reported that analysis of this device was completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONATE X4 CRT-D
Type of Device
IMPLANTABLE DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key9100591
MDR Text Key159516181
Report Number2124215-2019-17377
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589539
UDI-Public00802526589539
Combination Product (y/n)N
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 01/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/12/2021
Device Model NumberG447
Device Catalogue NumberG447
Device Lot Number214200
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/08/2019
Initial Date Manufacturer Received 07/31/2019
Initial Date FDA Received09/20/2019
Supplement Dates Manufacturer Received10/30/2019
Supplement Dates FDA Received01/07/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age75 YR
-
-